AKT1 and cervical carcinoma: Given our consideration of the AKT signaling pathway potentially as a therapeutically relevant target for cervical cancer cells highly expressing ZNF275, we further assessed the influence of triciribine and cisplatin on the biological behaviors of cervical cancer cells.